mrs CLAIRE ERNST

Regulation in healthcare: submitted written comment to House Small Business Committee on "Burdensome Red Tape: Overregulation in Health Care and the Impact on Small Businesses" hearing MACRA: supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act; submitted written comment to House Energy & Commerce Committee on MACRA Checkup: Assessing Implementation and Challenges that Remain for Patients and Doctors hearing Telehealth: submitted written comment to House Energy & Commerce Committee on the SUPPORT Act reauthorization Prior authorization: submitted written comment to the Senate Committee on Homeland Security and Government Affairs on Examining Health Care Denials and Delays in Medicare Advantage hearing Patient ID: joined sign-on letter to House and Senate appropriations leaderships to reject the inclusion of outdated rider language in Section 510 of the Fiscal Year 2024 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique patient health identifier standard HIPAA: submitted written comment to CMS on HIPAA attachment standards proposed rule CCM: supported H.R. 2829, Chronic Care Management Act of 2023 Labs: supported S. 1000 / H.R. 2377, the Saving Access to Laboratory Services Act (SALSA) Healthcare transparency: submitted written comment to House Ways and Means Committees on Health Care Price Transparency: A Patients Right to Know hearing HTI-1 proposals: submitted written comment to ONC regarding Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing proposed rule

Regulation in healthcare: submitted written comment to House Small Business Committee on "Burdensome Red Tape: Overregulation in Health Care and the Impact on Small Businesses" hearing MACRA: supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act; submitted written comment to House Energy & Commerce Committee on MACRA Checkup: Assessing Implementation and Challenges that Remain for Patients and Doctors hearing Telehealth: submitted written comment to House Energy & Commerce Committee on the SUPPORT Act reauthorization Prior authorization: submitted written comment to the Senate Committee on Homeland Security and Government Affairs on Examining Health Care Denials and Delays in Medicare Advantage hearing Patient ID: joined sign-on letter to House and Senate appropriations leaderships to reject the inclusion of outdated rider language in Section 510 of the Fiscal Year 2024 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique patient health identifier standard HIPAA: submitted written comment to CMS on HIPAA attachment standards proposed rule CCM: supported H.R. 2829, Chronic Care Management Act of 2023 Labs: supported S. 1000 / H.R. 2377, the Saving Access to Laboratory Services Act (SALSA) Healthcare transparency: submitted written comment to House Ways and Means Committees on Health Care Price Transparency: A Patients Right to Know hearing HTI-1 proposals: submitted written comment to ONC regarding Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing proposed rule

Regulation in healthcare: submitted written comment to House Small Business Committee on "Burdensome Red Tape: Overregulation in Health Care and the Impact on Small Businesses" hearing MACRA: supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act; submitted written comment to House Energy & Commerce Committee on MACRA Checkup: Assessing Implementation and Challenges that Remain for Patients and Doctors hearing Telehealth: submitted written comment to House Energy & Commerce Committee on the SUPPORT Act reauthorization Prior authorization: submitted written comment to the Senate Committee on Homeland Security and Government Affairs on Examining Health Care Denials and Delays in Medicare Advantage hearing Patient ID: joined sign-on letter to House and Senate appropriations leaderships to reject the inclusion of outdated rider language in Section 510 of the Fiscal Year 2024 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique patient health identifier standard HIPAA: submitted written comment to CMS on HIPAA attachment standards proposed rule CCM: supported H.R. 2829, Chronic Care Management Act of 2023 Labs: supported S. 1000 / H.R. 2377, the Saving Access to Laboratory Services Act (SALSA) Healthcare transparency: submitted written comment to House Ways and Means Committees on Health Care Price Transparency: A Patients Right to Know hearing HTI-1 proposals: submitted written comment to ONC regarding Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing proposed rule

Regulation in healthcare: submitted written comment to House Small Business Committee on "Burdensome Red Tape: Overregulation in Health Care and the Impact on Small Businesses" hearing MACRA: supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act; submitted written comment to House Energy & Commerce Committee on MACRA Checkup: Assessing Implementation and Challenges that Remain for Patients and Doctors hearing Telehealth: submitted written comment to House Energy & Commerce Committee on the SUPPORT Act reauthorization Prior authorization: submitted written comment to the Senate Committee on Homeland Security and Government Affairs on Examining Health Care Denials and Delays in Medicare Advantage hearing Patient ID: joined sign-on letter to House and Senate appropriations leaderships to reject the inclusion of outdated rider language in Section 510 of the Fiscal Year 2024 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique patient health identifier standard HIPAA: submitted written comment to CMS on HIPAA attachment standards proposed rule CCM: supported H.R. 2829, Chronic Care Management Act of 2023 Labs: supported S. 1000 / H.R. 2377, the Saving Access to Laboratory Services Act (SALSA) Healthcare transparency: submitted written comment to House Ways and Means Committees on Health Care Price Transparency: A Patients Right to Know hearing HTI-1 proposals: submitted written comment to ONC regarding Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing proposed rule

Medicare payment: Joined healthcare organization sign-on letter to extend APM incentive payments; sent letter to E&C Health Subcommittee on ways to reduce burden for medical groups re: Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors" hearing; response to W&M Improving Access to Health Care in Rural and Underserved Areas RFI; submitted comments on the 2024 proposed Physician Fee Schedule No Surprises Act: Testimony for W&M hearing on Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections Medical payment produces: Response to CFPB RFI about medical payment produces Prior authorization: Letter of support for the GOLD Card Act (HR 4968) and the Reducing Medically Unnecessary Delays in Care Act (HR 5213)

Medicare payment: Joined healthcare organization sign-on letter to extend APM incentive payments; sent letter to E&C Health Subcommittee on ways to reduce burden for medical groups re: Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors" hearing; response to W&M Improving Access to Health Care in Rural and Underserved Areas RFI; submitted comments on the 2024 proposed Physician Fee Schedule No Surprises Act: Testimony for W&M hearing on Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections Medical payment produces: Response to CFPB RFI about medical payment produces Prior authorization: Letter of support for the GOLD Card Act (HR 4968) and the Reducing Medically Unnecessary Delays in Care Act (HR 5213)

Medicare payment: Joined healthcare organization sign-on letter to extend APM incentive payments; sent letter to E&C Health Subcommittee on ways to reduce burden for medical groups re: Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors" hearing; response to W&M Improving Access to Health Care in Rural and Underserved Areas RFI; submitted comments on the 2024 proposed Physician Fee Schedule No Surprises Act: Testimony for W&M hearing on Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections Medical payment produces: Response to CFPB RFI about medical payment produces Prior authorization: Letter of support for the GOLD Card Act (HR 4968) and the Reducing Medically Unnecessary Delays in Care Act (HR 5213)

Medicare payment: Joined healthcare organization sign-on letter to extend APM incentive payments; sent letter to E&C Health Subcommittee on ways to reduce burden for medical groups re: Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors" hearing; response to W&M Improving Access to Health Care in Rural and Underserved Areas RFI; submitted comments on the 2024 proposed Physician Fee Schedule No Surprises Act: Testimony for W&M hearing on Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections Medical payment produces: Response to CFPB RFI about medical payment produces Prior authorization: Letter of support for the GOLD Card Act (HR 4968) and the Reducing Medically Unnecessary Delays in Care Act (HR 5213)

Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.

Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.

Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.

Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.

Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.

Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.

Regulation in healthcare: submitted written comment to House Small Business Committee on "Burdensome Red Tape: Overregulation in Health Care and the Impact on Small Businesses" hearing MACRA: supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act; submitted written comment to House Energy & Commerce Committee on MACRA Checkup: Assessing Implementation and Challenges that Remain for Patients and Doctors hearing Telehealth: submitted written comment to House Energy & Commerce Committee on the SUPPORT Act reauthorization Prior authorization: submitted written comment to the Senate Committee on Homeland Security and Government Affairs on Examining Health Care Denials and Delays in Medicare Advantage hearing Patient ID: joined sign-on letter to House and Senate appropriations leaderships to reject the inclusion of outdated rider language in Section 510 of the Fiscal Year 2024 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique patient health identifier standard HIPAA: submitted written comment to CMS on HIPAA attachment standards proposed rule CCM: supported H.R. 2829, Chronic Care Management Act of 2023 Labs: supported S. 1000 / H.R. 2377, the Saving Access to Laboratory Services Act (SALSA) Healthcare transparency: submitted written comment to House Ways and Means Committees on Health Care Price Transparency: A Patients Right to Know hearing HTI-1 proposals: submitted written comment to ONC regarding Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing proposed rule

Regulation in healthcare: submitted written comment to House Small Business Committee on "Burdensome Red Tape: Overregulation in Health Care and the Impact on Small Businesses" hearing MACRA: supported H.R. 2474, the Strengthening Medicare for Patients and Providers Act; submitted written comment to House Energy & Commerce Committee on MACRA Checkup: Assessing Implementation and Challenges that Remain for Patients and Doctors hearing Telehealth: submitted written comment to House Energy & Commerce Committee on the SUPPORT Act reauthorization Prior authorization: submitted written comment to the Senate Committee on Homeland Security and Government Affairs on Examining Health Care Denials and Delays in Medicare Advantage hearing Patient ID: joined sign-on letter to House and Senate appropriations leaderships to reject the inclusion of outdated rider language in Section 510 of the Fiscal Year 2024 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique patient health identifier standard HIPAA: submitted written comment to CMS on HIPAA attachment standards proposed rule CCM: supported H.R. 2829, Chronic Care Management Act of 2023 Labs: supported S. 1000 / H.R. 2377, the Saving Access to Laboratory Services Act (SALSA) Healthcare transparency: submitted written comment to House Ways and Means Committees on Health Care Price Transparency: A Patients Right to Know hearing HTI-1 proposals: submitted written comment to ONC regarding Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing proposed rule

Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.

Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.

Physician payment: provided statement on CMS CY 2023 physician fee schedule; urged Congress to prevent cuts to Medicare reimbursement Prior authorization: supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018)

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Provider Relief Fund: Letter to HRSA regarding replenishing the Uninsured Program. Value-based care: H.R.4587 - Value in Health Care Act of 2021 Surprise Billing: Submitted comments - Agency Information Collection Activities: Requirements Related to Surprise Billing: Qualifying Payment Amount, Notice and Consent, Disclosure on Patient Protections Against Balance Billing, and State Law Opt-in [CMS-10780] & Requirements Related to Surprise Billing; Part II [CMS-9908-IFC] Step therapy: Letter to HHS regarding step therapy practices for Part B drugs Appropriate Use Criteria (AUC): Letter to CMS regarding concerns about the AUC program OSHA: Letter to OSHA regarding healthcare permanent mandate Patient ID: Letter to Congress urging to repeal Section 510 in appropriations language PHE: Letter to HHS urging for the extension of the PHE LDTs: Letter to Congress urging to refine the VALID Act as drafted by Senate HELP SDOH: Letter to Congress to pass legislation to advance SDOH HITECH: Letter to HHS regarding provisions of HITECH Act Information blocking: Letter to HHS urging for more information opportunities regarding information blocking

Value-based care: H.R.4587 - Value in Health Care Act of 2021 Step therapy: Letter to HHS regarding step therapy practices for Part B drugs Appropriate Use Criteria: Letter to CMS regarding concerns about the AUC program

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided statement on CMS CY 2023 physician fee schedule; urged Congress to prevent cuts to Medicare reimbursement Prior authorization: supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018)

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Physician payment: provided comments to CMS re: proposed 2023 Physician Fee Schedule; support the Supporting Medicare Providers Act of 2022 (HR 8800); urge Congress to extend Medicare APM incentive payments GME: partnered with other organizations to urge Congress to increase support for GME Prior authorization: supported introduction of GOLD CARD Act of 2022 (H.R. 7995); supports passage of the Improving Seniors' Timely Care to Access Act (HR 3173/S 3018) Surprise billing: urged appropriate implementation timeline for No Surprises Act enforcement PHE: urge renewal of the COVID-19 PHE Information blocking: request additional clarity and guidance surrounding information blocking regulations; request that HHS postpone information blocking compliance deadlines Medicare advantage: provided comment for Medicare Advantage RFI Laboratory services: urge Congress to protect patient access to clinical laboratory services by supporting Saving Access to Laboratory Services Act (SALSA/H.R. 8188/S.4449) Telehealth: urge Senate to extend telehealth flexibilities

Graduate Medical Education (GME): (1) Sent a letter to the CMS Administrator with other healthcare organizations asking to finalize certain methodology in the FY 2022 Inpatient Prospective Payment System (IPPS) proposed rule, with modifications, and increase the number of full time equivalent (FTE) slots awarded per hospital for FY 2023 and all succeeding years. (2) Sent letter with other healthcare organizations asking to support the physician workforce in the upcoming infrastructure package by increasing the number of GME positions. Accountable Care Organizations (ACO): (1) Sent a letter of support to bill sponsors of the Accountable Care In Rural America Act (H.R. 3746), which amends title XVIII of the Social Security Act to improve the benchmarking process for the Medicare Shared Savings Program (MSSP) to ensure that all ACOs have an equal opportunity to share in savings regardless of their geographic location. (2) Sent a letter to HHS urging to extend Next Gen ACOs through 2022. CMS Administrator: Sent a letter welcoming Administrator Brooks-LaSure to CMS and outlining several MGMA administrative priorities for the year. CMMI: Sent a letter to CMMI Administrator Fowler welcoming her to CMMI and outlining recommendations for Alternative Payment Models (APMs). Provider Relief Fund (PRF): (1) Sent a letter to Secretary Becerra urging modifications to the PRF. (2) Sent a letter of support to the sponsors of Eliminating the Provider Relief Fund Tax Penalties Act (H.R. 2079), a bill which would eliminate the negative tax implications stemming from the PRF. HIPAA: Submitted comments on proposed modifications to the HIPAA Privacy Rule. MSSP: Sent letter to HHS asking to delay mandatory MSSP quality reporting changes. Medicare reimbursement cuts: Sent a letter to Congress urging them to address FY 2022 Medicare cuts in the infrastructure package. Telehealth: Submitted testimony on telehealth expansion for both the W&M and E&C Committee hearings regarding telehealth. Step Therapy: Sent a letter to CMS urging for reinstatement of the step therapy prohibition on Part B drugs in MA plans. MIPS: Sent a letter to CMS urging to release MIPS cost measure benchmark data Patient IDs: Sent a letter to Congress the reject the inclusion of rider language in the FY 2022 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique health identifier standard. OSHA COVID-19 Emergency Temporary Standard (ETS): Sent a letter to the Secretary of the Department of Labor asking to rescind or relay the OSHA healthcare ETS.

Chronic Care Management: Letter in support of the Seniors' Chronic Care Management Improvement Act of 2021 (H.R. 4755) Prior Authorization: Statement in support of the Improving Seniors' Timely Access to Care Act of 2021 (H.R. 3173) Telehealth: Letter outlining priorities for Medicare telehealth reform Electronic Funds Transfer (EFT): Letter to CMS calling on the Agency to use its authority to prohibit EFT fees Alternative Payment Models (APMs): Letter to Congress asking for inclusion of Value in Health Care Act of 2021(H.R. 4587) in the Reconciliation bill pursuant to the FY 2022 Budget Resolution. Letter to HHS urging to advance health equity and value through APMs Graduate Medical Education (GME): Letter to Congress urging to increase Medicare support for GME Physician Fee Schedule (PFS): Comments on proposed CY 2022 PFS. Letter to Congress asking to maintain the 3.75% increase to the CY 2022 conversion factor.

Graduate Medical Education (GME): (1) Sent a letter to the CMS Administrator with other healthcare organizations asking to finalize certain methodology in the FY 2022 Inpatient Prospective Payment System (IPPS) proposed rule, with modifications, and increase the number of full time equivalent (FTE) slots awarded per hospital for FY 2023 and all succeeding years. (2) Sent letter with other healthcare organizations asking to support the physician workforce in the upcoming infrastructure package by increasing the number of GME positions. Accountable Care Organizations (ACO): (1) Sent a letter of support to bill sponsors of the Accountable Care In Rural America Act (H.R. 3746), which amends title XVIII of the Social Security Act to improve the benchmarking process for the Medicare Shared Savings Program (MSSP) to ensure that all ACOs have an equal opportunity to share in savings regardless of their geographic location. (2) Sent a letter to HHS urging to extend Next Gen ACOs through 2022. CMS Administrator: Sent a letter welcoming Administrator Brooks-LaSure to CMS and outlining several MGMA administrative priorities for the year. CMMI: Sent a letter to CMMI Administrator Fowler welcoming her to CMMI and outlining recommendations for Alternative Payment Models (APMs). MSSP: Sent letter to HHS asking to delay mandatory MSSP quality reporting changes. Medicare reimbursement cuts: Sent a letter to Congress urging them to address FY 2022 Medicare cuts in the infrastructure package. Telehealth: Submitted testimony on telehealth expansion for both the W&M and E&C Committee hearings regarding telehealth. Step Therapy: Sent a letter to CMS urging for reinstatement of the step therapy prohibition on Part B drugs in MA plans. MIPS: Sent a letter to CMS urging to release MIPS cost measure benchmark data

Graduate Medical Education (GME): (1) Sent a letter to the CMS Administrator with other healthcare organizations asking to finalize certain methodology in the FY 2022 Inpatient Prospective Payment System (IPPS) proposed rule, with modifications, and increase the number of full time equivalent (FTE) slots awarded per hospital for FY 2023 and all succeeding years. (2) Sent letter with other healthcare organizations asking to support the physician workforce in the upcoming infrastructure package by increasing the number of GME positions. Accountable Care Organizations (ACO): (1) Sent a letter of support to bill sponsors of the Accountable Care In Rural America Act (H.R. 3746), which amends title XVIII of the Social Security Act to improve the benchmarking process for the Medicare Shared Savings Program (MSSP) to ensure that all ACOs have an equal opportunity to share in savings regardless of their geographic location. (2) Sent a letter to HHS urging to extend Next Gen ACOs through 2022. CMS Administrator: Sent a letter welcoming Administrator Brooks-LaSure to CMS and outlining several MGMA administrative priorities for the year. CMMI: Sent a letter to CMMI Administrator Fowler welcoming her to CMMI and outlining recommendations for Alternative Payment Models (APMs). Provider Relief Fund (PRF): (1) Sent a letter to Secretary Becerra urging modifications to the PRF. (2) Sent a letter of support to the sponsors of Eliminating the Provider Relief Fund Tax Penalties Act (H.R. 2079), a bill which would eliminate the negative tax implications stemming from the PRF. HIPAA: Submitted comments on proposed modifications to the HIPAA Privacy Rule. MSSP: Sent letter to HHS asking to delay mandatory MSSP quality reporting changes. Medicare reimbursement cuts: Sent a letter to Congress urging them to address FY 2022 Medicare cuts in the infrastructure package. Telehealth: Submitted testimony on telehealth expansion for both the W&M and E&C Committee hearings regarding telehealth. Step Therapy: Sent a letter to CMS urging for reinstatement of the step therapy prohibition on Part B drugs in MA plans. MIPS: Sent a letter to CMS urging to release MIPS cost measure benchmark data Patient IDs: Sent a letter to Congress the reject the inclusion of rider language in the FY 2022 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from spending any federal dollars to promulgate or adopt a national unique health identifier standard. OSHA COVID-19 Emergency Temporary Standard (ETS): Sent a letter to the Secretary of the Department of Labor asking to rescind or relay the OSHA healthcare ETS.

Chronic Care Management: Letter in support of the Seniors' Chronic Care Management Improvement Act of 2021 (H.R. 4755) Prior Authorization: Statement in support of the Improving Seniors' Timely Access to Care Act of 2021 (H.R. 3173) Telehealth: Letter outlining priorities for Medicare telehealth reform Electronic Funds Transfer (EFT): Letter to CMS calling on the Agency to use its authority to prohibit EFT fees Alternative Payment Models (APMs): Letter to Congress asking for inclusion of Value in Health Care Act of 2021(H.R. 4587) in the Reconciliation bill pursuant to the FY 2022 Budget Resolution. Letter to HHS urging to advance health equity and value through APMs Graduate Medical Education (GME): Letter to Congress urging to increase Medicare support for GME Physician Fee Schedule (PFS): Comments on proposed CY 2022 PFS. Letter to Congress asking to maintain the 3.75% increase to the CY 2022 conversion factor.

Chronic Care Management: Letter in support of the Seniors' Chronic Care Management Improvement Act of 2021 (H.R. 4755) Prior Authorization: Statement in support of the Improving Seniors' Timely Access to Care Act of 2021 (H.R. 3173) Telehealth: Letter outlining priorities for Medicare telehealth reform Electronic Funds Transfer (EFT): Letter to CMS calling on the Agency to use its authority to prohibit EFT fees Alternative Payment Models (APMs): Letter to Congress asking for inclusion of Value in Health Care Act of 2021(H.R. 4587) in the Reconciliation bill pursuant to the FY 2022 Budget Resolution. Letter to HHS urging to advance health equity and value through APMs Graduate Medical Education (GME): Letter to Congress urging to increase Medicare support for GME Physician Fee Schedule (PFS): Comments on proposed CY 2022 PFS. Letter to Congress asking to maintain the 3.75% increase to the CY 2022 conversion factor.

Surprise Medical Billing: Submitted comments to HHS on requirements related to surprise medical billing. Letter to HHS urging to revise QPA element of IDR process Prior authorization: Statement in support of S. 3018, Improving Seniors' Timely Access to Care Act of 2021 Electronic Funds Transfer (EFT): Letter to CMS calling on the Agency to use its authority to prohibit EFT fees Alternative Payment Models (APMs): Letter to CMS urging it to allow benchmarking flexibility for MSSP ACOs MIPS: Letter to Congress urging for extension of QPP-SURS program Graduate Medical Education (GME): Letter to Congress urging to increase Medicare support for GME Physician Fee Schedule (PFS): Letter to House Ways and Means Committee, urging hearing on Medicare payment cuts. Statement in support of legislation to avert cuts to Medicare payment in CY 2022 Labs: Letter to Congress asking to prevent cuts to physician labs in CY 2022

Surprise Medical Billing: Submitted comments to HHS on requirements related to surprise medical billing. Letter to HHS urging to revise QPA element of IDR process Prior authorization: Statement in support of S. 3018, Improving Seniors' Timely Access to Care Act of 2021 Electronic Funds Transfer (EFT): Letter to CMS calling on the Agency to use its authority to prohibit EFT fees Alternative Payment Models (APMs): Letter to CMS urging it to allow benchmarking flexibility for MSSP ACOs MIPS: Letter to Congress urging for extension of QPP-SURS program Graduate Medical Education (GME): Letter to Congress urging to increase Medicare support for GME Physician Fee Schedule (PFS): Letter to House Ways and Means Committee, urging hearing on Medicare payment cuts. Statement in support of legislation to avert cuts to Medicare payment in CY 2022 Labs: Letter to Congress asking to prevent cuts to physician labs in CY 2022

Issues: Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021 Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress MIPS: advocated to administration for reductions in reporting burden for 2021 Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program National Patient Identifier: advocated for the development of a national approach to matching patient records Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency Bills: HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes

Issues: Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021 Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress MIPS: advocated to administration for reductions in reporting burden for 2021 Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program National Patient Identifier: advocated for the development of a national approach to matching patient records Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency Bills: HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes

Issues: Telehealth: Advocated for an extension of the telehealth waivers implemented during the COVID-19 public health emergency APMs: Communicated value based care priorities for medical groups Provider Relief Funds from CARES Act: Advocated for grant funding for group practices under the Public Health and Social Services Fund Paycheck Protection Program: Advocated for more guidance and information from SBA in order for medical groups to understand and comply with the program Specific Bills: H.R. 7010: Paycheck Protection Program Flexibility Act of 2020, all provisions relating to the Paycheck Protection Program H.R. 748: CARES Act, all provisions relating to the Paycheck Protection Program, the Provider Relief Fund, and Medicare telehealth H.R. 266: Paycheck Protection Program and Health Care Enhancement Act, all provisions relating to Provider Relief Funds and Paycheck Protection Program

Issues: Telehealth: Advocated for an extension of the telehealth waivers implemented during the COVID-19 public health emergency APMs: Communicated value based care priorities for medical groups Provider Relief Funds from CARES Act: Advocated for grant funding for group practices under the Public Health and Social Services Fund Paycheck Protection Program: Advocated for more guidance and information from SBA in order for medical groups to understand and comply with the program Specific Bills: H.R. 7010: Paycheck Protection Program Flexibility Act of 2020, all provisions relating to the Paycheck Protection Program H.R. 748: CARES Act, all provisions relating to the Paycheck Protection Program, the Provider Relief Fund, and Medicare telehealth H.R. 266: Paycheck Protection Program and Health Care Enhancement Act, all provisions relating to Provider Relief Funds and Paycheck Protection Program

Issues: Telehealth: Advocated for an extension of the telehealth waivers implemented during the COVID-19 public health emergency APMs: Communicated value based care priorities for medical groups Provider Relief Funds from CARES Act: Advocated for grant funding for group practices under the Public Health and Social Services Fund Paycheck Protection Program: Advocated for more guidance and information from SBA in order for medical groups to understand and comply with the program Specific Bills: H.R. 7010: Paycheck Protection Program Flexibility Act of 2020, all provisions relating to the Paycheck Protection Program H.R. 748: CARES Act, all provisions relating to the Paycheck Protection Program, the Provider Relief Fund, and Medicare telehealth H.R. 266: Paycheck Protection Program and Health Care Enhancement Act, all provisions relating to Provider Relief Funds and Paycheck Protection Program

Issues: Telehealth: Advocated for an extension of the telehealth waivers implemented during the COVID-19 public health emergency APMs: Communicated value based care priorities for medical groups Provider Relief Funds from CARES Act: Advocated for grant funding for group practices under the Public Health and Social Services Fund Paycheck Protection Program: Advocated for more guidance and information from SBA in order for medical groups to understand and comply with the program Medicare evaluation and management codes/budget neutrality: Advocated for Congress and/or CMS to waive Medicare budget neutrality requirements to prevent payment cuts to reimbursement in 2021 Specific Bills: H.R. 8505 H.R. 7663 H.R. 7791

Issues: Telehealth: Advocated for an extension of the telehealth waivers implemented during the COVID-19 public health emergency APMs: Communicated value based care priorities for medical groups Provider Relief Funds from CARES Act: Advocated for grant funding for group practices under the Public Health and Social Services Fund Paycheck Protection Program: Advocated for more guidance and information from SBA in order for medical groups to understand and comply with the program Medicare evaluation and management codes/budget neutrality: Advocated for Congress and/or CMS to waive Medicare budget neutrality requirements to prevent payment cuts to reimbursement in 2021 Specific Bills: H.R. 8505 H.R. 7663 H.R. 7791

Issues: Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021 Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress MIPS: advocated to administration for reductions in reporting burden for 2021 Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program National Patient Identifier: advocated for the development of a national approach to matching patient records Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency Bills: HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes

Issues: Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021 Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress MIPS: advocated to administration for reductions in reporting burden for 2021 Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program National Patient Identifier: advocated for the development of a national approach to matching patient records Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency Bills: HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes

Issues: Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021 Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress MIPS: advocated to administration for reductions in reporting burden for 2021 Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program National Patient Identifier: advocated for the development of a national approach to matching patient records Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency Bills: HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes

Issues: Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021 Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress MIPS: advocated to administration for reductions in reporting burden for 2021 Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program National Patient Identifier: advocated for the development of a national approach to matching patient records Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency Bills: HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes

Issues: Telehealth: Advocated for an extension of the telehealth waivers implemented during the COVID-19 public health emergency APMs: Communicated value based care priorities for medical groups Provider Relief Funds from CARES Act: Advocated for grant funding for group practices under the Public Health and Social Services Fund Paycheck Protection Program: Advocated for more guidance and information from SBA in order for medical groups to understand and comply with the program Medicare evaluation and management codes/budget neutrality: Advocated for Congress and/or CMS to waive Medicare budget neutrality requirements to prevent payment cuts to reimbursement in 2021 Specific Bills: H.R. 8505 H.R. 7663 H.R. 7791

Issues: Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021 Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress MIPS: advocated to administration for reductions in reporting burden for 2021 Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program National Patient Identifier: advocated for the development of a national approach to matching patient records Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency Bills: HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes

Issues: Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021 Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress MIPS: advocated to administration for reductions in reporting burden for 2021 Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program National Patient Identifier: advocated for the development of a national approach to matching patient records Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency Bills: HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes